MIA Reports

Deprescribing Psychiatric Drugs to Reduce Harms and Empower Patients: Interview with Psychiatrist Swapnil Gupta

10
Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

8
Philosopher Justin Garson discusses the potential benefit of looking at madness not as disease or defect, but as a designed feature.
A white brain surrounded by a pile of red and white pills

Depression: Psychiatry’s Discredited Theories and Drugs Versus a Sane Model and Approach

78
Psychiatry’s depression outcomes are poor because its bio-chemical-electrical treatments are based on a depression model that science has flushed down the toilet.
Photo of a girl surrounded by bullies holding cell phones

“A Dangerous Substance”: The Impact of Social Media on Youth Mental Health

6
This is what social media does, she says. It draws people in. It hurts people. In the worst cases, it kills people.
AI-generated image of a snowy yeti and an ice-crusted double-helix

Searching for the “Psychiatric Yeti”: Schizophrenia Is Not Genetic

170
After decades of study, billions of dollars spent, and thousands of studies conducted, the failure to identify any genes for schizophrenia should definitively put to rest the notion that schizophrenia is a genetic disorder, according to E. Fuller Torrey.

The Psychological Humanities Manifesto: An Interview with Mark Freeman

13
Justin Karter interviews narrative and philosophical psychologist Mark Freeman about his vision for the future of psychology.
Woman holding a smartphone and touching the screen, she is using mobile apps, vintage style collage

Therapy by App: A Clinical Psychologist Tries BetterHelp

35
Revealing concerns about BetterHelp’s ability to provide quality, secure treatment—and the unresolved tensions in the science of psychotherapy that services like BetterHelp exploit.

Winding Back the Clock: What If the STAR*D Investigators Had Told the Truth?

26
The STAR*D Study has been cited as real-world evidence of the efficacy of antidepressants. In truth, it told of a failed paradigm of care.

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

9
In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.

Robert Whitaker Answers Reader Questions on Mad in America, the Biopsychosocial Model, and Psychiatric...

32
On the Mad in America podcast this week we have Robert Whitaker with us to answer questions sent in by readers and listeners.

After MIA Calls for Retraction of STAR*D Article, Study Authors Double Down on the...

24
In their letter to the editor, Rush et al. have doubled-down on the fraud they committed in their 2006 summary report of STAR*D outcomes.

The Making of a ‘Madness’ That Hides Our Monsters: An Interview with Audrey Clare...

13
In this interview, Audrey Clare Farley reveals how our understanding of schizophrenia was built to avoid acknowledging sexual trauma, religious abuse, and racism.

The WHO and the United Nations: Let Freedom Ring for the Mad

23
This is a call that challenges how psychiatry is practiced today and ultimately challenges its power in society.

May Cause Side Effects–Radical Acceptance and Psychiatric Drug Withdrawal: An Interview with Brooke Siem

11
Brooke Siem discusses her experiences of being medicated with antidepressants as a teenager, her withdrawal from a cocktail of psychiatric drugs and her debut memoir, May Cause Side Effects.
A girl wearing virtual reality device over eyes looks startled with hands wide and mouth open

Why Failed Psychiatry Lives On: Its Industrial Complex, Politics, & Technology Worship

44
By embracing the widely popular technology-worship “religion,” psychiatry is permitted to ignore the reality that its repeated failures are evidence that its fundamental paradigm is misguided.

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

22
MIA’s Ayurdhi Dhar interviews Ray Moynihan about the marketing of disorders, broadening of diagnoses, and harmful treatments.

How Mad Studies and the Psychological Humanities are Changing Mental Health: An Interview with...

55
In this interview with MIA's Justin Karter, psychiatrist Bradley Lewis discusses the value of art, the humanities, and mad studies in shaping a richer understanding of psychological experiences.

Embracing the Shadow—Charlie Morley on Lucid Dreaming as Therapy

3
On the Mad in America podcast, we hear about the potential of lucid dreaming therapy to aid those struggling with post-traumatic stress.

Family Panel Discussion – Supporting a Child, Teen, or Young Person in Crisis

4
Supporting a Child, Teen, or Young Person in Crisis - Our guest panel, Ciara Fanlo, Morna Murray and Sami Timimi join host Amy Biancolli to share stories of crisis but also stories of healing and of hope.

‘Sacred Conversations’: A Talk with Susan Swim and a Father Whose Daughter Found Healing

6
We have two guests today. One is Susan Swim, executive director of the Now I See A Person Institute, which she created in 2007...